Dr. Filion is a tenured Associate Professor jointly appointed in the Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health and a William Dawson Scholar at McGill University in Montreal, Canada. He is also a Senior Investigator at the Center for Clinical Epidemiology of the Lady Davis Institute of the Jewish General Hospital and an Investigator in the McGill Pharmacoepidemiology Research Unit. Dr. Filion leads an independent research program focused on pharmacoepidemiology and the use of large, population-based databases to study the effectiveness, safety, and utilization of prescription drugs in real-world settings. The primary substantive area of his research is cardiometabolic conditions, including cardiovascular disease and diabetes. Dr. Filion is a Steering Committee member of the Canadian Network for Observational Drug Effect Studies (CNODES), a pan-Canadian drug safety network funded by the Canadian Institutes of Health Research that addresses emerging questions of drug safety and effectiveness posed by key government stakeholders. He is supported by a Senior salary support award from the Fonds de recherche du Québec – santé (Quebec Foundation for Research – Health). He was elected as a Fellow of the American Heart Association.
SER